Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M321Revenue (TTM) $M9.0Net Margin (%)-261.8Altman Z-Score24.2
Enterprise Value $M258EPS (TTM) $-0.5Operating Margin %-273.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.9Pre-tax Margin (%)-257.2Higher ROA y-yN
Price/Book4.710-y EBITDA Growth Rate %-2.7Quick Ratio14.9Cash flow > EarningsY
Price/Sales36.05-y EBITDA Growth Rate %5.1Current Ratio14.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-26.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-28.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M50.9ROIC % (ttm)-139.5Gross Margin Increase y-yY

Gurus Latest Trades with CGEN

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CGEN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CGEN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about CGEN:

    News about CGEN:

    Articles On GuruFocus.com

    More From Other Websites
    Compugen Announces Key Highlights from R&D Day Dec 07 2016
    Compugen Discloses its Cancer Immunotherapy Program Targeting TIGIT Immune Checkpoint Dec 07 2016
    Compugen Appoints Senior Vice President Corporate and Business Development Dec 05 2016
    Compugen Ltd. breached its 50 day moving average in a Bearish Manner : CGEN-US : November 22, 2016 Nov 22 2016
    Compugen to Present at 28th Annual Piper Jaffray Healthcare Conference in New York Nov 21 2016
    Compugen Immune Checkpoint Program Demonstrates Potential for Development of New Cancer... Nov 11 2016
    Compugen Immune Checkpoint Program Demonstrates Potential for Development of New Cancer... Nov 11 2016
    ETF’s with exposure to Compugen Ltd. : November 10, 2016 Nov 10 2016
    Compugen Ltd. :CGEN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 9, 2016 Nov 09 2016
    Compugen Ltd. Reports 3rd Quarter 2016 Financial Results Nov 07 2016
    Compugen reports 3Q loss Nov 07 2016
    Compugen reports 3Q loss Nov 07 2016
    Compugen Ltd. Reports 3rd Quarter 2016 Financial Results Nov 07 2016
    Compugen to Host R&D Day on December 7, 2016 in New York Nov 03 2016
    Compugen to Host R&D Day on December 7, 2016 in New York Nov 03 2016
    Compugen Third Quarter Financial Statements to be Released November 7, 2016 Oct 10 2016
    Compugen Third Quarter Financial Statements to be Released November 7, 2016 Oct 10 2016
    Compugen to Present at the Annual Meeting of the Society for Immunotherapy of Cancer Next Month Oct 07 2016
    ETF’s with exposure to Compugen Ltd. : September 28, 2016 Sep 28 2016
    Compugen Ltd. – Value Analysis (NASDAQ:CGEN) : September 19, 2016 Sep 19 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)